BLRX
BioLineRX
BLRX
BLRX
24 hedge funds and large institutions have $13.9M invested in BioLineRX in 2019 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 4 increasing their positions, 2 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
86% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 7
Holders
24
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$175K | |
| 2 | +$57K | |
| 3 | +$12.2K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.3K |
| 5 |
DWM
Doyle Wealth Management
St. Petersburg,
Florida
|
+$1K |
Top Sellers
| 1 | -$157K | |
| 2 | -$33K | |
| 3 | -$16K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$14K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5K |